Menu
Member Login
  • Home
  • About Us
    • Board of Directors
    • Committees
    • Bylaws
    • History
  • Membership
    • Member Benefits
    • Renew My Membership
  • Services
    • Attorney Referral Service
    • Find an Attorney Referral
    • Expert Witness Service
    • Find an Expert Witness
  • Events
    • Fall Conference
    • ASPL Track at APhA
  • Awards
    • Larry M. Simonsmeier Award
    • Joseph L. Fink Award
    • Fink Family Scholarship
  • Resources
    • Links to Other Organizations
    • Job Opportunities
  • Member Center
    • Login
  • Contact Us



Search

Attorney Referral Service - Listing


The ASPL Attorney Referral Service allows interested parties to connect with a lawyer who is an expert in Pharmacy Law.

Click here view the full Attorney Referral Service Listing.



Narrow your search by zip code, state, city or Referral Service expertise.






Sort By Distance
 

Quick Links

  • Join Now
  • Meetings
  • Find an Attorney
  • Find an Expert

Latest News

April 16, 2018

DRUG PRICING
4th Circuit finds Maryland price gouging statute unconstitutional
Friday the 13th was unlucky for Maryland’s statute, HB 361, in that the 4th Circuit Court of Appeals found the law violated the dormant commerce clause. The statute prohibited manufacturers of generic drugs or their wholesalers from “making unconscionable increases in the price of an ‘essential off-patent or generic drug,’” according to a report in the FDA Law Blog. The Maryland Medical Assistance Program (MMAP) was required to notify the Maryland Attorney General when an increase in the wholesale acquisition cost (WAC) of a drug increased by at least 50% in the prior year, or when the price to MMAP would increase by at least 50% in one year, and when the WAC for a 30-day supply or a full treatment exceeded $80. The AG was provided with civil remedies including injunction, monetary relief, and civil penalties for violations.

Plaintiffs, the Association for Accessible Medicines (AAM) – formerly known as the Generic Pharmaceutical Association - sued in federal court and challenged the statute on constitutional grounds: (1) violation of the dormant commerce clause and (2) impermissible vagueness in violation of the due process clause of the 14th Amendment. The district court granted Maryland’s motion to dismiss the dormant commerce clause challenge, but allowed the due process claim to proceed. AAM appealed to the 4th Circuit. According to FDA Law Blog’s summary, a divided panel of the 4th Circuit relied on 3 determinations to find a violation of the dormant commerce clause: (1) the law’s focus on the price initially charged by the manufacturer, not on the price paid by a Maryland consumer; (2) the fact that the manufacturer’s initial sale triggered a violation, even if no nexus to Maryland could be demonstrated; and (3) if other states followed suit, it would impose a significant burden on interstate commerce. [Schlanger SJ, Kirchenbaum AM. Fourth Circuit finds Maryland price gouging law unconstitutional. FDA Law Blog 2018 Apr 15; https://bit.ly/2H4IhFU; Association for Accessible Medicines v. Frosh et al., No. 17-2166, 4th Cir., April 13, 2018]

 

 

Announcements

ASPL
DPL XXVIV Seminar
November 1-4, 2018
Hilton Head Island, SC

More Information

© American Society for Pharmacy Law
3085 Stevenson Drive, Suite 200 Springfield, IL 62703

  • LinkedIn
  • Twitter
powered by MemberClicks